Polymarket Market
Prediction market
Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.
Upcoming
- Probability
- 47%
- Liquidity
- $27.79K
- Best bid
- 1%
- Best ask
- 99%
- Spread
- 98%
- Last trade
- 47%
Outcomes
Market outcomes
Live pricing
Pricing and liquidity
Current bid, ask, midpoint, spread, and market depth for this outcome.
- Best bid
- 1%
- Best ask
- 99%
- Midpoint
- 50%
- Spread
- 98%
- Last trade
- 47%
- Depth
- 26,341.7 / 1,451.7
Price history
Waiting for price history
History unavailable
Bids
| Price | Size |
|---|---|
| 1% | 18,900 |
| 2% | 19.59 |
| 10% | 1,800 |
| 11% | 3,289 |
| 12% | 27.44 |
| 16% | 450 |
| 21% | 300 |
| 22% | 641 |
Asks
| Price | Size |
|---|---|
| 99% | 9.48 |
| 96% | 500 |
| 95% | 15.94 |
| 92% | 108 |
| 91% | 22 |
| 86% | 50 |
| 81% | 433 |
| 77% | 17.7 |
Trades
Recent trades
Latest visible trades for this market.
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?No 47% 0.36 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?No 47% 7.8 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?No 47% 10.21 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?No 18% 10.21 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 54.2% 21.31 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 52% 19.94 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 52% 57 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 52% 19.94 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 51% 5.06 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 62% 5.27 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?No 38% 104.72 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?No 38% 50 shares